Eventos adversos relacionados ao cateter venoso central em pacientes internados em um hospital de ensino

• Autor(a) principal: Melo, Matheus Santos
• Data de Publicação: 2020
• Outros Autores: Oliveira, Carilene Silva, Rodrigues, Iellen Dantas Campos Verdes, Souza, Cibelle Alves Doria de, Sousa, Clara Santana, Mendonça, Simonize Cunha Barreto de, Resende, Luana Teles de, Andrade, Joseilze Santos de
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Enfermagem Atual In Derme
• Texto Completo: https://revistaenfermagematual.com/index.php/revista/article/view/747
• topic: Cateteres; Segurança do Paciente; Vigilância em Saúde.

The objective of the study is to describe adverse events related to the use of the Central Venous Catheter (CVC). This is a descriptive, longitudinal and prospective observational study, conducted with 81 adult and pediatric patients, who use CVC during their hospitalization, for more than 48 hours, without a period from June to November 2017 in a public teaching hospital. medium-sized, state of Sergipe, Brazil. After approval by the Research Ethics Committee, data were collected using an active search form, according to the information contained in the patient's medical record. 104 CVCs were monitored, with an average of 1.3 per patient, with an average length of stay of 11 days (SD = 8). The highest incidence rates of adverse events occurred in the ICU (39.4%). The mean age was 52 years (SD ± 19), with a predominance of females (56.7%). The cumulative global incidence of adverse events was 40.7%, with an incidence density of 26.1 per 1000 CVC-days. The frequency of infectious adverse events (48.5%) was canceled out from non-infectious adverse events (51.5%), with insertion site infection (ISI - CVC) standing out among the infectious (39.9%) and , among non-infectious events, a loss of catheter (24.2%). Eleven deaths were recorded, 27.3% of which were adverse events during the observation period. It was evidenced that the infection of the insertion site (ISIC-VC) was the main adverse event identified in this study, mainly in individuals admitted to the ICU and in the female sex.